Abnormal expression of RERG is associated with tumorigenesis, progression, and metastasis, with downregulation observed in several cancer types, including colorectal cancer (Yang et al., 2014; Xiong et al., 2019). The gene discussed is RERG; the disease is colorectal cancer.